| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Atara Biotherapeutics, Inc. (ATRA) has 3 insiders with recent SEC Form 4 filings, including 0 buys and 30 sells. ATRA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 1.32M | $13.99M | - | |
| CEO | 143.1K | $1.51M | - | |
| Other | 52.0K | $549.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 2, 2019 | Newell Joe85 | Chief Tech. Operations Officer | Sale+OE | 1,500 | $38.01 | $57,020.00 | -2.3% | |
| Jan 24, 2019 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 7,800 | $35.06 | $273,433.20 | -0.5% | |
| Jan 10, 2019 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 7,800 | $34.55 | $269,470.00 | -21.6% | |
| Jan 2, 2019 | Newell Joe85 | Chief Tech. Operations Officer | Sale+OE | 1,500 | $35.00 | $52,500.00 | -4.5% | |
| Dec 28, 2018 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 7,800 | $33.88 | $264,232.61 | -12.1% | |
| Dec 13, 2018 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 7,800 | $42.66 | $332,709.00 | -15.3% | |
| Dec 3, 2018 | Newell Joe85 | Chief Tech. Operations Officer | Sale+OE | 1,500 | $41.14 | $61,704.11 | -1.5% | |
| Nov 29, 2018 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 7,800 | $40.39 | $315,035.00 | -6.0% | |
| Nov 15, 2018 | Haqq Christopher | EVP, R&D &Chief Scientific Of | Sell | 775 | $33.81 | $26,202.75 | -0.3% | |
| Nov 15, 2018 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 7,800 | $34.62 | $270,052.00 | -4.9% |